The U.S. Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of blood culture and antimicrobial susceptibility testing (AST)/identification (ID) reagents and diagnostic platforms. The contract has a total ceiling value of $2,462,079.76 and a period of performance through April 30, 2031, with no set-aside designation. The BPA includes two specific task orders, valued at $321,304.35 and...
The U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 23 (VISN 23), has awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the delivery of test kit reagents and associated diagnostic platforms. This single-award BPA, with a total ceiling value of $14,732,632.16, is part of Biomerieux's existing Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits. The...
The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of BIOFIRE MOLECULAR TESTING products and services. The $209,568.78 contract, which has a period of performance through September 30, 2025, is under the VA's Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits. Biomerieux Inc., through its Biomerieux, Inc. division, will supply the VA with its...
Biomerieux Inc., a global leader in in vitro diagnostics, was awarded a single-award Indefinite Delivery Contract (IDC) by the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 23. The contract, valued at $135,660.00, is for the maintenance and support of Biomerieux's specialized diagnostic equipment and platforms installed at VA healthcare facilities. The contract has an ultimate completion date of September 30, 2027, with the first two task orders valued at...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a single award Indefinite Delivery Contract to Biomerieux Inc. with a potential value of $7.4 million to provide identification, antimicrobial susceptibility testing, and matrix-assisted laser desorption/ionization clinical proteomics technology solutions. The original solicitation posted on January 18, 2023 sought these laboratory diagnostic testing equipment and services with a...
This single-award Indefinite Delivery Contract (IDC) was issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) to Biomerieux Inc., a global diagnostics manufacturer, to provide an Automated Blood Culture System and associated reagents. The $2,000,000 contract has a period of performance through September 30, 2025. Biomerieux will deliver its proprietary VITEK, BioFire, and VIDAS platforms, consumables, and technical support services to support...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 23 (VISN 23) awarded a single-award, $549,984.84 Indefinite Delivery Contract to Biomerieux Inc. for the provision of Vitek 2 and Vitek MS microbiology diagnostic testing supplies. The contract has a 5-year period of performance from October 1, 2023 to September 30, 2024. Under this IDC, the VA VISN 23 will issue firm-fixed-price delivery orders to Biomerieux's Emigration Canyon, Utah...
Biomerieux Inc., a global leader in in vitro diagnostics, was awarded a Blanket Purchase Agreement (BPA) by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration under its Federal Supply Schedule (FSS) contract for Critical Analyzers, Laboratory (FSS-66-III). The BPA and subsequent task orders, valued at over $1.4 million, provide the VA with Biomerieux's specialized microbiology testing platforms, reagents, test kits, and technical support services for blood culture...
The Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to Biomerieux Inc. for VISN 8 Molecular Pathogen Detection. The contract, valued at $31,825,821.12, has an ultimate completion date of January 12, 2030, and was awarded on January 13, 2025. Under this IDC, Biomerieux Inc., through its Biomerieux, Inc. Division, will provide in-vitro diagnostic test panels, equipment, and related services to support molecular pathogen detection capabilities at...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded Biomerieux Inc. multiple blanket purchase agreements and call contracts from April 2023 through September 2024 totalling approximately $215,000. Biomerieux Inc. will provide VIDAS diagnostic testing platforms, reagents, and related services as the prime contractor. Performance will occur at Biomerieux's facility in Emigration Canyon, Utah to support infectious disease testing for...